Key Metrics
8.3
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.98
5-Year SI
5-year SI
- N/A 2-year SI
- 0.95 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
0.83
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Topics Covered
- Reactive oxygen species
- Lung cancer
- Camptothecin
- Drug delivery
- Breast cancer
- Nanomedicine
- Assay
- Doxorubicin
- Bioavailability
- Extracellular vesicles
- Autophagy
- Nanocarriers
- Iron oxide nanoparticles
- Tumor microenvironment
- Neuroscience research
- Bilirubin
- Glioblastoma
- Photodynamic therapy
- Rheumatoid arthritis
- Gemcitabine
Journal Specifications
| Overview | |
| Publisher | FUTURE MEDICINE LTD |
| Language | English |
| Frequency | Semi-monthly |
| General Details | |
| Language | English |
| Frequency | Semi-monthly |
| Publication Start Year | 2006 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Nanomedicine ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Photodynamic immunotherapy using ADU-S100-modified nanoparticles to treat triple-negative breast cancer
- 1 Apr 23
- Nanomedicine
-
Full paper
Targeted delivery of panitumumab-scaffold bosutinib-encapsulated polycaprolactone nanoparticles for EGFR-overexpressed colorectal cancer
- 1 Apr 23
- Nanomedicine
-
Full paper
Prophylactic and therapeutic role of catechin-loaded poly(D,L-lactic-co-glycolic acid) nanocapsules in gastric ulcer by <i>in vitro</i> and <i>in vivo</i> approach
- 1 Feb 23
- Nanomedicine
-
Full paper
Therapeutic outcome of quercetin nanoparticles on <i>Cerastes cerastes</i> venom-induced hepatorenal toxicity: a preclinical study
- 1 Feb 23
- Nanomedicine
-
Full paper
Polylactic-co-glycolic acid-based nanoparticles modified with peptides and other linkers cross the blood–brain barrier for targeted drug delivery
- 1 Jan 23
- Nanomedicine
-
Full paper
Human solid tumors and clinical relevance of the enhanced permeation and retention effect: a ‘golden gate’ for nanomedicine in preclinical studies?
- 1 Jan 23
- Nanomedicine
Scite analysis
Powered by scite_
3.2k articles received 80.6k citations see all
- 1,702 Supporting
- 78,145 Mentioning
- 82 Contrasting
Editorial notices
- 6 Retractions
- 0 Withdrawals
- 0 Corrections
- 18 Errata
- 0 Expression of Concern
FAQs
How long has Nanomedicine been actively publishing?
Nanomedicine has been in operation since 2006 till date.
What is the publishing frequency of Nanomedicine ?
Nanomedicine published with a Semi-monthly frequency.
How many articles did Nanomedicine publish last years ?
In 2023, Nanomedicine published 6 articles.
What is the eISSN & pISSN for Nanomedicine ?
For Nanomedicine,eISSN is 1748-6963 and pISSN is1743-5889.
What is Citescore for Nanomedicine ?
Citescore for Nanomedicine is 8.3.
What is SNIP score for Nanomedicine ?
SNIP score for Nanomedicine is 0.83.
Who is the publisher of Nanomedicine ?
FUTURE MEDICINE LTD is the publisher of Nanomedicine.